Unfolding the Therapeutic Potential of Chemical Chaperones for Age-related Macular Degeneration.
Recent studies suggest that pathological processes involved in age-related macular degeneration (AMD) might induce endoplasmic reticulum (ER) stress. Growing evidence demonstrates the ability of chemical chaperones to decrease ER stress and ameliorate ER stress-related disease phenotypes, suggesting that the field of chaperone therapy might hold novel treatments for AMD. In this review, we examine the evidence suggesting a role for ER stress in AMD. Furthermore, we discuss the use of chaperone therapy for the treatment of ER stress-associated diseases, including other neurodegenerative diseases and retinopathies. Finally, we examine strategies for identifying potential chaperone compounds and for experimentally demonstrating chaperone activity in in vitro and in vivo models of human disease.
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Theodor
T
Sauer
Mrinali
M
Patel
Chi-Chao
CC
Chan
Jingsheng
J
Tuo